Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Barry Greene Net Worth & Insider Trades

Barry Greene - Director, Karyopharm Therapeutics Inc

As of May 25, 2023

What is Barry Greene's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's Director, Barry Greene, is estimated to be about $80.77M . Barry Greene owns about 3,000 units of Karyopharm Therapeutics Inc common stock. In the last 8 years at Karyopharm Therapeutics Inc, Barry Greene has sold an estimated value of $0 worth.

What is Barry Greene's Past Insider Trading?

Barry Greene's largest purchase order was 3,000 units , worth over $87.94K on April 6, 2015. In total, Barry Greene has made about 12 transactions over 8 years of their time at Karyopharm Therapeutics Inc. Barry Greene usually trades in May, with the busiest year in 2015, 2022 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Barry Greene

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Barry Greene's' Mailing Address?

  • Mailing address is C/o Acorda Therapeutics 420 Saw Mill River Road Ardsley NY 10502 NY

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on November 7, 2023 by Richard Paulson who sold 3,606 units worth $3.32K . In the last 10 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $148.24M and bought an estimated value of $33.49M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...